Cineverse (CNVS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
2 Feb, 2026Executive summary
Q1 FY25 revenue was $9.1 million, down 30% year-over-year, mainly due to timing of digital content releases and non-recurring legacy business revenues.
SG&A expenses decreased by $1.3 million (17%) year-over-year, driven by offshoring, operational consolidation, and lower compensation and legal fees.
Direct operating margin rose to 51%, exceeding the 45%-50% target.
Net loss attributable to common stockholders was $3.2 million, or $(0.20) per share, improved from $3.6 million, or $(0.37) per share, with an accumulated deficit of $507.3 million.
Built a robust sales pipeline in SaaS, AI, and advertising, with expected revenue upsides from new product launches and the October 2024 release of Terrifier 3.
Financial highlights
Total revenue declined by $3.9 million year-over-year, with streaming and digital revenue down $2.4 million and non-recurring legacy digital cinema revenue down $1.2 million.
Direct operating expenses fell by $2.5 million (36%) year-over-year, reflecting lower licensing, royalty, and fulfillment costs.
Adjusted EBITDA was -$1.4 million, a slight improvement from -$1.5 million year-over-year.
Cash and equivalents stood at $4.0 million as of June 30, 2024; working capital facility usage decreased to $4.7 million.
Net loss per share was $(0.20), compared to $(0.37) in the same quarter last year.
Outlook and guidance
Expects double-digit revenue growth for FY25 as economic conditions and advertising market improve.
Management anticipates significant revenue growth from new sales initiatives, proprietary technology, AI products, and the October 2024 release of Terrifier 3.
Direct operating margin expected to remain within 45%-51% range.
Anticipates being operating cash flow positive for full FY25, with cash balances sufficient for at least twelve months.
Ongoing net losses are expected in the foreseeable future, with legacy cinema equipment revenue continuing to decline.
Latest events from Cineverse
- Registering 21.8M shares for resale, with proceeds from warrants to fund growth and content.CNVS
Registration Filing17 Mar 2026 - Revenue down 60% year-over-year; FY27 guidance boosted by accretive acquisitions.CNVS
Q3 202617 Feb 2026 - Adjusted EBITDA rose to $4.4M on cost cuts, margin gains, and new channel growth.CNVS
Q4 20243 Feb 2026 - Q2 revenue up 20% (ex-digital cinema); Terrifier 3 to drive major future profit gains.CNVS
Q2 202513 Jan 2026 - Record revenue and net income, zero debt, and strong growth driven by Terrifier 3.CNVS
Q3 20252 Dec 2025 - Annual meeting to vote on directors, pay, equity plan, and auditor, with focus on ESG and governance.CNVS
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, compensation, equity plan, and auditor, with ESG focus.CNVS
Proxy Filing1 Dec 2025 - Annual Meeting to vote on directors, compensation, equity plan, and auditor, with ESG focus.CNVS
Proxy Filing1 Dec 2025 - Definitive proxy materials filed for shareholder voting and SEC compliance.CNVS
Proxy Filing1 Dec 2025